Sironax
3 known investors
Sironax develops treatments that target underlying contributors of degeneration, including disrupted energy homeostasis, dysregulated cell death, and inflammation, across multiple organs and tissues. The company focuses on conditions related to aging, degeneration, and metabolic dysfunction.
BiotechHealthtechLongevity